CXCL5 and prostate neoplasm: Immunostaining for CXCL5 and CCL23 in a representative cohort of archival prostate tissues displayed significantly higher CXCL5 in prostate tumors than in adjacent benign tissues, while CCL23 was non-detectable in most of the analyzed tumor tissues.